Center for Scientific Review; Notice of Closed Meetings, 73284 [2020-25285]
Download as PDF
73284
Federal Register / Vol. 85, No. 222 / Tuesday, November 17, 2020 / Notices
person prior to the meeting date. An
oral public comment period will be
scheduled at each meeting. Time
allotted for each commenter will be
limited to three minutes. If the number
of speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
public comment period, ONC will take
written comments after the meeting.
Persons attending in-person HITAC
meetings are advised that the agency is
not responsible for providing wireless
access or access to electrical outlets.
ONC welcomes the attendance of the
public at its HITAC meetings. Seating is
limited at in-person meetings, and ONC
will make every effort to accommodate
persons with physical disabilities or
special needs. If you require special
accommodations due to a disability,
please contact Lauren Richie at least
seven (7) days in advance of the
meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: November 9, 2020.
Lauren Richie,
Designated Federal Officer, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2020–25261 Filed 11–16–20; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Population Science and
Epidemiology B.
Date: December 8, 2020.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
19:46 Nov 16, 2020
Jkt 253001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 594–
6594, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Prevention and Mechanisms
of Cancer Therapeutics.
Date: December 8, 2020.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, (301) 435–
1719, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Hypersensitivity and Mucosal Immunology
Mechanisms.
Date: December 9, 2020.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4207,
MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Biostatistical Methods and Research Design.
Date: December 10, 2020.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 594–
6594, steeleln@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 10, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25285 Filed 11–16–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer
Advisory Board and NCI Board of
Scientific Advisors.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations to view the meeting,
should notify the Contact Person listed
below in advance of the meeting. The
meeting will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The intramural programs and projects
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the
intramural programs and projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Date: November 30, 2020.
Closed: 12:00 p.m. to 1:00 p.m.
Agenda: Review of intramural program site
visit outcomes and the discussion of
confidential personnel issues.
Open: 1:15 p.m. to 4:45 p.m.
Agenda: NCAB Subcommittee Meetings—
Subcommittee on Planning and Budget; Ad
Hoc Subcommittee on Experimental
Therapeutics; and Ad Hoc Subcommittee on
Population Science, Epidemiology and
Disparities.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Date: December 1, 2020.
Open: 1:00 p.m. to 5:00 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors, NCI Director’s report and
presentations, NCI Board of Scientific
Advisors Concepts Review.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
E:\FR\FM\17NON1.SGM
17NON1
Agencies
[Federal Register Volume 85, Number 222 (Tuesday, November 17, 2020)]
[Notices]
[Page 73284]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25285]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Population Science and Epidemiology B.
Date: December 8, 2020.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D., Scientific Review Officer,
PSE IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD
20892, (301) 594-6594, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Prevention and Mechanisms of Cancer
Therapeutics.
Date: December 8, 2020.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, (301) 435-1719, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Hypersensitivity and Mucosal Immunology Mechanisms.
Date: December 9, 2020.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4207, MSC 7812, Bethesda, MD 20892, (301) 435-
1238, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Biostatistical Methods and Research Design.
Date: December 10, 2020.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D., Scientific Review Officer,
PSE IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD
20892, (301) 594-6594, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 10, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-25285 Filed 11-16-20; 8:45 am]
BILLING CODE 4140-01-P